Elsevier

Neuroscience Letters

Volume 396, Issue 1, 20 March 2006, Pages 67-72
Neuroscience Letters

Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

https://doi.org/10.1016/j.neulet.2005.11.012Get rights and content

Abstract

The progressive degenerative process associated with sporadic Parkinson's disease (sPD) is characterized by formation of α-synuclein-containing inclusion bodies in a few types of projection neurons in both the enteric and central nervous systems (ENS and CNS). In the brain, the process apparently begins in the brainstem (dorsal motor nucleus of the vagal nerve) and advances through susceptible regions of the basal mid-and forebrain until it reaches the cerebral cortex. Anatomically, all of the vulnerable brain regions are closely interconnected. Whether the pathological process begins in the brain or elsewhere in the nervous system, however, is still unknown. We therefore used immunocytochemisty to investigate the gastric myenteric and submucosal plexuses in 150 μm cryosections and 8 μm paraffin sections from five autopsy individuals, whose brains were also staged for Parkinson-associated synucleinopathy. α-synuclein immunoreactive inclusions were found in neurons of the submucosal Meissner plexus, whose axons project into the gastric mucosa and terminate in direct proximity to fundic glands. These elements could provide the first link in an uninterrupted series of susceptible neurons that extend from the enteric to the central nervous system. The existence of such an unbroken neuronal chain lends support to the hypothesis that a putative environmental pathogen capable of passing the gastric epithelial lining might induce α-synuclein misfolding and aggregation in specific cell types of the submucosal plexus and reach the brain via a consecutive series of projection neurons.

Section snippets

Acknowledgements

This work has received financial support from the Deutsche Forschungsgemeinschaft (grant number Br317/17-2). Autopsies were performed in compliance with ethics committee guidelines of all three participating institutions. We thank B. Meseck-Selchow (laboratory assistance) and I. Szász-Jacobi (graphics) for technical support. We declare that we have no existing or pending conflicts of interest.

References (30)

  • J.E. Ahlskog

    Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease

    Mov. Disord.

    (2005)
  • M. Anlauf et al.

    Chemical coding of the human gastroinstestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes

    J. Comp. Neurol.

    (2003)
  • H. Braak et al.

    Neuropathological stageing of Alzheimer-related changes

    Acta Neuropathol.

    (1991)
  • H. Braak et al.

    Stages in the development of Parkinson's disease-related pathology

    Cell Tissue Res.

    (2004)
  • H. Braak et al.

    Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

    J. Neural. Transm.

    (2003)
  • Cited by (1079)

    • Towards a biological diagnosis of PD

      2024, Parkinsonism and Related Disorders
    View all citing articles on Scopus
    View full text